Literature DB >> 35488695

Erratum: Role of antifibrotic drugs in the management of post-COVID-19 interstitial lung disease: A review of literature and report from an expert working group.

.   

Abstract

[This corrects the article DOI: 10.4103/lungindia.lungindia_659_21].

Entities:  

Year:  2022        PMID: 35488695      PMCID: PMC9200201          DOI: 10.4103/0970-2113.343593

Source DB:  PubMed          Journal:  Lung India        ISSN: 0970-2113


In the article titled “Role of antifibrotic drugs in the management of post-COVID-19 interstitial lung disease: A review of literature and report from an expert working group”, published on pages 177-186, Issue 2, Volume 39 of Lung India[1], the third author’s name is incorrectly written as “Sahajal Dhoori.” The correct author’s name should read as “Sahajal Dhooria.” The “How to cite this article” section should read correctly as ”Salvi SS, Ghorpade D, Dhooria S, Dhar R, Dumra H, Chhajed PN, et al. Role of antifibrotic drugs in the management of post-COVID-19 interstitial lung disease: A review of literature and report from an expert working group. Lung India 2022;39:177-86”.
  1 in total

1.  Role of antifibrotic drugs in the management of post-COVID-19 interstitial lung disease: A review of literature and report from an expert working group.

Authors:  Sundeep Santosh Salvi; Deesha Ghorpade; Sahajal Dhoori; Raja Dhar; Harjit Dumra; Prashant N Chhajed; Parathasarathi Bhattacharya; Sujeet Rajan; Deepak Talwar; Devasahayam J Christopher; Murali Mohan; Zarir Udwadia
Journal:  Lung India       Date:  2022 Mar-Apr
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.